Yumanity Therapeutics to Present at the BTIG Virtual Biotechnology Conference

Yumanity Therapeutics Inc

Fri, Aug 6, 2021, 7:00 AM1 min read

BOSTON, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced that Company management will participate in a fireside chat at the BTIG Virtual Biotechnology Conference on Tuesday, August 10, 2021, at 1:00 p.m. ET.

BTIG hosted events are intended for prospective and existing BTIG clients only. To listen to the live event, please contact your BTIG representative.

About Yumanity Therapeutics
Yumanity Therapeutics is a clinical-stage biopharmaceutical company dedicated to accelerating the revolution in the treatment of neurodegenerative diseases through its scientific foundation and drug discovery platform. The Company’s most advanced product candidate, YTX-7739, is currently in Phase 1 clinical development for Parkinson’s disease. Yumanity’s drug discovery platform enables the Company to rapidly screen for potential disease-modifying therapies by overcoming the toxicity of misfolded proteins associated with neurogenerative diseases. Yumanity’s pipeline consists of additional programs focused on Lewy body dementia, multi-system atrophy, amyotrophic lateral sclerosis (ALS or Lou Gehrig’s disease), frontotemporal lobar dementia (FTLD), and Alzheimer’s disease. For more information, please visit www.yumanity.com.

Investors:
Burns McClellan, Inc.
Lee Roth
lroth@burnsmc.com
(212) 213-0006

Media:
Burns McClellan, Inc.
Robert Flamm, Ph.D. / Harrison Wong
rflamm@burnsmc.com / hwong@burnsmc.com
(212) 213-0006 ext. 364 / 316

Dow Jones Futures Fall As Israel Strikes Iran; Stock Market About To Break Power Trend
Futures fell on reports of Iran explosions: The market power trend is about to end. Netflix gave weak guidance.
Investor's Business Daily•10m ago
Don't buy the dip in stocks just yet as a wave of selling is about to bring the market to a bottom, according to one of the biggest bulls on Wall Street
The S&P 500 could bottom out in the next month, according to Fundstrat's head of research Tom Lee.
Business Insider•4h ago
Stocks Slump, Havens Surge on Mideast: Markets Wrap
(Bloomberg) -- Global markets were rocked by fresh conflict in the Middle East that sent stocks lower while oil and haven assets including Treasures and the dollar rallied.Most Read from BloombergElon Wants His Money BackDubai Grinds to Standstill as Flooding Hits CityRecord Rainfall in Dubai? Blame Climate Change, Not Cloud SeedingSingapore Loses ‘World’s Best Airport’ Crown to QatarRed Lobster Considers Bankruptcy to Deal With Leases and Labor CostsGains for Treasuries sent the 10-year yield a
Bloomberg•23m ago
Trump Media stock jumps for second day as company goes to battle with short sellers
Trump Media is advising investors on ways to prevent their shares from being loaned for a short-interest position.
Yahoo Finance•12h ago
The Most Active Stock Trader in Congress Is Buying Shares of This Magnificent Stock-Split Stock
Wall Street's most-prominent stock-split stock of 2024 has been purchased on three separate occasions by a lawmaker who completed over 4,200 trades last year.
Motley Fool•20h ago
Billionaire Warren Buffett Recently Cut This Stock From Berkshire Hathaway's Portfolio. It Just Dropped 53% In 1 Day. Here's What Investors Need to Know.
The insurer was accused by a short-seller of "extensive" fraud.
Motley Fool•2d ago
Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending'
In the chaos of the 2008 recession, perhaps no bank stood more prepared than Jamie Dimon's J.P Morgan Chase & Co. (NYSE:JPM). In advance of the crisis, Jamie Dimon realized that "underwriting standards were deteriorating across the industry," with late payments on subprime loans rising. In late 2006, the bank led his firm to exit Wall Street's hot subprime business, starting with a frantic call made to J.P. Morgan's vacationing Chief of Securitized Products where he said, "I really want you to w
Benzinga•14h ago
Cathie Wood buys $14 million of Tesla stock
Her flagship Ark Innovation ETF has lost 18% this year.
TheStreet•5h ago
DJT Stock Jumps. The Truth Social Owner Is Showing Stockholders How to Block Short Sellers.
An FAQ on the Truth Social owner’s website gave stockholders multiple ways to avoid their shares being lent to short sellers.
Barrons.com•8h ago
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Pfizer stock remains under pressure despite becoming one of the biggest names of the pandemic. Is PFE stock a sell?
Investor's Business Daily•13h ago

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Yumanity Therapeutics to Present at the BTIG Virtual Biotechnology Conference

Recommended Stories

Dow Jones Futures Fall As Israel Strikes Iran; Stock Market About To Break Power Trend

Don't buy the dip in stocks just yet as a wave of selling is about to bring the market to a bottom, according to one of the biggest bulls on Wall Street

Stocks Slump, Havens Surge on Mideast: Markets Wrap

Trump Media stock jumps for second day as company goes to battle with short sellers

The Most Active Stock Trader in Congress Is Buying Shares of This Magnificent Stock-Split Stock

Billionaire Warren Buffett Recently Cut This Stock From Berkshire Hathaway's Portfolio. It Just Dropped 53% In 1 Day. Here's What Investors Need to Know.

Jamie Dimon Knew Subprime 'Could Go Up In Smoke'; Now He's Worried About An Artificial Economy 'Fueled by Government Deficit Spending'

Cathie Wood buys $14 million of Tesla stock

DJT Stock Jumps. The Truth Social Owner Is Showing Stockholders How to Block Short Sellers.

Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?